COVID-19: systemic pathology and its implications for therapy

Int J Biol Sci. 2022 Jan 1;18(1):386-408. doi: 10.7150/ijbs.65911. eCollection 2022.

Abstract

Responding to the coronavirus disease 2019 (COVID-19) pandemic has been an unexpected and unprecedented global challenge for humanity in this century. During this crisis, specialists from the laboratories and frontline clinical personnel have made great efforts to prevent and treat COVID-19 by revealing the molecular biological characteristics and epidemic characteristics of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, SARS-CoV-2 has severe consequences for public health, including human respiratory system, immune system, blood circulation system, nervous system, motor system, urinary system, reproductive system and digestive system. In the review, we summarize the physiological and pathological damage of SARS-CoV-2 to these systems and its molecular mechanisms followed by clinical manifestation. Concurrently, the prevention and treatment strategies of COVID-19 will be discussed in preclinical and clinical studies. With constantly unfolding and expanding scientific understanding about COVID-19, the updated information can help applied researchers understand the disease to build potential antiviral drugs or vaccines, and formulate creative therapeutic ideas for combating COVID-19 at speed.

Keywords: SARS-CoV-2; immune system; immunotherapy; motor system; nervous system; reproductive system.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • COVID-19 / pathology*
  • COVID-19 / therapy*
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines
  • Cytokines / metabolism
  • Female
  • Humans
  • Immune System
  • Immunity, Innate
  • Immunologic Memory
  • Immunotherapy / methods*
  • Male
  • Mice
  • SARS-CoV-2*

Substances

  • Antiviral Agents
  • COVID-19 Vaccines
  • Cytokines